North Bud Farms Inc. (NBUD:CSE), through its subsidiary Growpros MMP Inc., is pursuing a license under the access to cannabis for medical purposes regulations (ACMPR). Northbud is dedicated to the production of both pharmaceutical and food grade cannabinoid inputs. Northbud recently became a reporting issuer in Ontario and is now listed on the Canadian Securities Exchange (CSE) under the symbol NBUD.
INVESTMENT MERITS:
- Publicly listed corporation pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR)
- Cultivation facility is located ~10 km from the Paugan Hydro-Electric generating station, a plentiful source of clean, powerful, sustainable and inexpensive energy
- Focused on sustainable production and procurement of cannabinoids. We assist clients in developing Cannabinoid Infused Products (CIP) as well as Active Pharmaceutical Ingredients (API)
- Positioned as a leader in Legalization 2.0, which will emerge as regulations unfold over the coming year
- Will be growing GMP pharmaceutical grade and food grade cannabis, which is currently in short supply
- Has access to a diverse genetic portfolio, which it will leverage for its Legalization 2.0 pharmaceutical and food and beverage partners
